Data as of Aug 27
| +1.05 / +4.98%|
The 7 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 24.00, with a high estimate of 66.06 and a low estimate of 14.91. The median estimate represents a +7.85% increase from the last price of 22.26.
The current consensus among 9 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.